14-day Premium Trial Subscription Try For FreeTry Free

NYSE:ENZ

Enzo Biochem Inc Stock News

New York Stock Exchange > Healthcare > Diagnostics & Research

Open Broker Account

$1.16

+0.0300 (+2.65%)

At Close: Jun 14, 2024

Enzo Biochem Stakeholder Harbert Discovery Fund Sends Letter To Shareholders Encouraging Them To Vote For Fund's Board Nominees

12:00am, Monday, 30'th Dec 2019

The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares

12:56pm, Tuesday, 10'th Dec 2019

The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeut

Earnings Scheduled For December 10, 2019

09:43am, Tuesday, 10'th Dec 2019

Companies Reporting Before The Bell Conn's, Inc. (NASDAQ: CONN ) is estimated to report quarterly earnings at $0.54 per share on revenue of $394.29 million. HD Supply Holdings, Inc. (NASDAQ: HDS ) is

Enzo Biochem Board To Consider Alternatives For Co.'s Therapeutics Subsidiary, Including Spin Off, Sale, Joint Venture Or License Of IP

12:00am, Tuesday, 10'th Dec 2019

Enzo Biochem Sends Letter To Shareholders; Notes 'Short-Term Activist' Harbert Seeking Fire Sale Of Co. At 'Depressed Prices'; Urges Vote 'For' On White Proxy Card

12:00am, Thursday, 05'th Dec 2019

Roumell Asset Management, LLC Buys Zagg Inc, comScore Inc, Leaf Group, Sells Enzo Biochem Inc, ...

12:00am, Wednesday, 13'th Nov 2019

Enzo Biochem Q4 EPS $(0.11) Up From $(0.12) YoY, Sales $20.921M Beat $19.66M Estimate

12:00am, Tuesday, 15'th Oct 2019

New York State Health Department Approves Enzo Clinical Labs Hepatitis B Virus Quantitative Clinical Assay

12:00am, Tuesday, 24'th Sep 2019

35 Healthcare Stocks Moving In Wednesday's After-Market Session

12:00am, Thursday, 25'th Jul 2019

Enzo Biochem Announces 3 Transformative Initiatives

12:00am, Thursday, 11'th Jul 2019

66 Biggest Movers From Yesterday

12:00am, Wednesday, 12'th Jun 2019

Enzo Biochem shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.

12:00am, Tuesday, 11'th Jun 2019

Enzo Biochem Q3 Adj. EPS $(0.14) Beats $(0.15) Estimate, Sales $22.3M Beat $19.31M Estimate

12:00am, Monday, 10'th Jun 2019

50 Biggest Movers From Yesterday

12:00am, Wednesday, 22'nd May 2019

Enzo Biochem Inc. Announces Issuance Of United States Patent For Treatment Of Liver Cancer Using Ozanimod

12:00am, Friday, 10'th May 2019

Sign In